Artificial intelligence for clinical oncology

BH Kann, A Hosny, HJWL Aerts - Cancer Cell, 2021 - cell.com
Clinical oncology is experiencing rapid growth in data that are collected to enhance cancer
care. With recent advances in the field of artificial intelligence (AI), there is now a …

Nomograms in oncology: more than meets the eye

VP Balachandran, M Gonen, JJ Smith… - The lancet …, 2015 - thelancet.com
Nomograms are widely used as prognostic devices in oncology and medicine. With the
ability to generate an individual probability of a clinical event by integrating diverse …

The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an …

A Pollack, TG Karrison, AG Balogh, LG Gomella… - The Lancet, 2022 - thelancet.com
Background In men with a detectable prostate-specific antigen (PSA) level after
prostatectomy for prostate cancer, salvage prostate bed radiotherapy (PBRT) results in …

Radiation with or without antiandrogen therapy in recurrent prostate cancer

WU Shipley, W Seiferheld, HR Lukka… - … England Journal of …, 2017 - Mass Medical Soc
Background Salvage radiation therapy is often necessary in men who have undergone
radical prostatectomy and have evidence of prostate-cancer recurrence signaled by a …

Prostate cancer, version 1.2016

JL Mohler, AJ Armstrong, RR Bahnson… - Journal of the National …, 2016 - jnccn.org
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an
initial diagnosis of prostate cancer and management options for localized, regional, and …

Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are …

JJ Morigi, PD Stricker, PJ van Leeuwen… - Journal of nuclear …, 2015 - Soc Nuclear Med
In prostate cancer with biochemical failure after therapy, current imaging techniques have a
low detection rate at the prostate-specific antigen (PSA) levels at which targeted salvage …

Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy

RD Tendulkar, S Agrawal, T Gao… - Journal of Clinical …, 2016 - ascopubs.org
Purpose We aimed to update a previously published, multi-institutional nomogram of
outcomes for salvage radiotherapy (SRT) following radical prostatectomy (RP) for prostate …

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a …

C Carrie, A Hasbini, G de Laroche, P Richaud… - The Lancet …, 2016 - thelancet.com
Background How best to treat rising prostate-specific antigen (PSA) concentration after
radical prostatectomy is an urgent clinical question. Salvage radiotherapy delays the need …

68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact …

J Calais, J Czernin, M Cao, AU Kishan… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Target volume delineations for prostate cancer (PCa) salvage radiotherapy (SRT) after
radical prostatectomy are usually drawn in the absence of visibly recurrent disease. 68Ga …

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

M Bolla, H van Poppel, B Tombal, K Vekemans… - The Lancet, 2012 - thelancet.com
Background We report the long-term results of a trial of immediate postoperative irradiation
versus a wait-and-see policy in patients with prostate cancer extending beyond the prostate …